PL2356247T3 - Sposób wytwarzania czynnika VII wolnego od surowicy i wolnego od insuliny - Google Patents

Sposób wytwarzania czynnika VII wolnego od surowicy i wolnego od insuliny

Info

Publication number
PL2356247T3
PL2356247T3 PL09826577T PL09826577T PL2356247T3 PL 2356247 T3 PL2356247 T3 PL 2356247T3 PL 09826577 T PL09826577 T PL 09826577T PL 09826577 T PL09826577 T PL 09826577T PL 2356247 T3 PL2356247 T3 PL 2356247T3
Authority
PL
Poland
Prior art keywords
free
factor vii
insulin
producing serum
serum
Prior art date
Application number
PL09826577T
Other languages
English (en)
Other versions
PL2356247T5 (pl
Inventor
Fircks Simone Von
Ruth Elmer
Manfred Reiter
Original Assignee
Baxalta Inc
Baxalta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42165541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2356247(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta Inc, Baxalta GmbH filed Critical Baxalta Inc
Publication of PL2356247T3 publication Critical patent/PL2356247T3/pl
Publication of PL2356247T5 publication Critical patent/PL2356247T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09826577T 2008-11-12 2009-11-05 Sposób wytwarzania czynnika VII wolnego od surowicy i wolnego od insuliny PL2356247T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11379208P 2008-11-12 2008-11-12
PCT/US2009/063338 WO2010056584A1 (en) 2008-11-12 2009-11-05 Method of producing serum-free insulin-free factor vii
EP09826577.0A EP2356247B2 (en) 2008-11-12 2009-11-05 Method of producing serum-free insulin-free factor vii

Publications (2)

Publication Number Publication Date
PL2356247T3 true PL2356247T3 (pl) 2016-04-29
PL2356247T5 PL2356247T5 (pl) 2019-10-31

Family

ID=42165541

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09826577T PL2356247T5 (pl) 2008-11-12 2009-11-05 Sposób wytwarzania czynnika VII wolnego od surowicy i wolnego od insuliny

Country Status (15)

Country Link
US (1) US20100120093A1 (pl)
EP (2) EP2977461A1 (pl)
JP (1) JP5719301B2 (pl)
AU (1) AU2009314345B2 (pl)
CA (1) CA2742107A1 (pl)
DK (1) DK2356247T4 (pl)
ES (1) ES2547881T5 (pl)
HK (1) HK1219113A1 (pl)
HR (1) HRP20151054T4 (pl)
HU (1) HUE026210T2 (pl)
IL (1) IL212355A (pl)
PL (1) PL2356247T5 (pl)
PT (1) PT2356247E (pl)
SI (1) SI2356247T2 (pl)
WO (1) WO2010056584A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2807607A1 (en) * 2010-08-20 2012-02-23 Wyeth Llc Cell culture of growth factor-free adapted cells
MY188828A (en) 2010-09-17 2022-01-06 Takeda Pharmaceuticals Co Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
AR095196A1 (es) * 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
KR20150026024A (ko) * 2013-08-30 2015-03-11 한미약품 주식회사 인간 혈액응고 7인자 유도체의 대량 생산 방법
US11286292B2 (en) 2014-02-07 2022-03-29 Cmc Biologics A/S Bioreactor arrangement and continuous process for producing and capturing a biopolymer
KR102570755B1 (ko) 2014-04-16 2023-08-24 씨엠씨 바이올로직스 에이/에스 고 세포 밀도의 유입 및 배출 발효 공정
PL3152317T3 (pl) 2014-06-04 2019-08-30 Amgen Inc. Sposoby zbierania hodowli ssaczych komórek

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456591A (en) 1981-06-25 1984-06-26 Baxter Travenol Laboratories, Inc. Therapeutic method for activating factor VII
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5997864A (en) 1995-06-07 1999-12-07 Novo Nordisk A/S Modified factor VII
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
AT407255B (de) * 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
WO2001011021A1 (de) * 1999-08-05 2001-02-15 Baxter Aktiengesellschaft Rekombinanter stabiler zellklon, seine herstellung und verwendung
US20030204338A1 (en) 2002-04-22 2003-10-30 Peter Martinek Method and measurement probe for the performance of measurements in water supply systems
IL154880A0 (en) * 2000-10-02 2003-10-31 Novo Nordisk As Method for the production of vitamin k-dependent proteins
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
CA2460206C (en) 2001-10-02 2012-01-24 Novo Nordisk Health Care Ag Method for production of recombinant proteins in eukaryote cells
US20050214289A1 (en) * 2004-03-26 2005-09-29 Human Genome Sciences, Inc. Antibodies against Nogo receptor
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
ATE541919T1 (de) * 2005-02-11 2012-02-15 Novo Nordisk Healthcare Ag Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält
CN101300342A (zh) * 2005-11-02 2008-11-05 惠氏公司 用于使哺乳动物细胞具备适应性的方法
EP2522717B1 (en) * 2006-01-04 2014-04-02 Baxter International Inc Oligopeptide-free cell culture media

Also Published As

Publication number Publication date
EP2356247B2 (en) 2019-05-15
DK2356247T4 (da) 2019-06-03
US20100120093A1 (en) 2010-05-13
DK2356247T3 (en) 2015-09-21
PL2356247T5 (pl) 2019-10-31
IL212355A (en) 2016-04-21
HK1219113A1 (zh) 2017-03-24
CA2742107A1 (en) 2010-05-20
EP2356247A4 (en) 2013-01-02
AU2009314345B2 (en) 2015-02-12
ES2547881T3 (es) 2015-10-09
EP2356247A1 (en) 2011-08-17
HRP20151054T1 (en) 2015-11-20
JP2012508562A (ja) 2012-04-12
IL212355A0 (en) 2011-06-30
AU2009314345A1 (en) 2011-06-30
ES2547881T5 (es) 2019-10-16
HRP20151054T4 (hr) 2019-11-15
HUE026210T2 (en) 2016-05-30
EP2356247B1 (en) 2015-07-15
PT2356247E (pt) 2015-10-26
SI2356247T2 (sl) 2019-08-30
WO2010056584A1 (en) 2010-05-20
EP2977461A1 (en) 2016-01-27
SI2356247T1 (sl) 2015-11-30
JP5719301B2 (ja) 2015-05-13

Similar Documents

Publication Publication Date Title
HK1219113A1 (zh) 無血清無胰島素的第七因子生產方法
EP2326707A4 (en) PROCESS FOR PRODUCING ISOPRENOIDS
EP2353174A4 (en) METHOD FOR PRODUCING SUBSTRATES
EP2353173A4 (en) METHODS OF MANUFACTURING SUBSTRATES
EP2353175A4 (en) METHODS OF MANUFACTURING SUBSTRATES
IL248217B (en) A method for the production of inganol-3-englate
EP2325153A4 (en) PROCESS FOR PREPARING ALUMINUM DIAMOND COMPOUND
PL2376507T3 (pl) Sposób otrzymywania hydroksymetylofosfonianów
IL216894A0 (en) Method of producing advanced composite components
EP2415464A4 (en) METHOD FOR PRODUCING A LIPOSOME COMPOSITION
EP2080510A4 (en) METHOD FOR PRODUCING A LIPOSOME PREPARATION
GB0711697D0 (en) Method of manufacture
EP2233548A4 (en) PROCESS FOR PRODUCING FERROCOKE
GB2452823B (en) Method of producing fluoroapatite
EP2650336A4 (en) METHOD FOR PRODUCING A WATERGLASS COATING COMPOSITION
HK1152202A1 (en) Method of producing nutritionally-enriched rice
EP2266943A4 (en) PROCESS FOR PRODUCING 2-ALKYL-2-CYCLOALCENE-1-ONE
EP2284144A4 (en) POLYFLUORO-1-ALKANE AND METHOD FOR PRODUCING THE SAME
GB0903805D0 (en) Method of manufacturing composite parts
ZA201002350B (en) Producing method of direct reduced iron
EP2197859A4 (en) PROCESS FOR PRODUCING BENZOXAZINONE-BASED COMPOUND
EP2305612A4 (en) METHOD FOR PRODUCING A GRIN LENS
EP2254508A4 (en) METHODS OF FABRICATION OF ENHANCED CARTILAGE OF TISSUE ENGINEERING
ZA201105114B (en) Method of manufacturing components
PL385356A1 (pl) Sposób wytwarzania tadalafilu